During the Phase III BROOKLYN trial, patients were randomly assigned in a 2:1 ratio to receive either obicetrapib 10mg or a ...

In addition, reductions in triglycerides and atherogenic proteins such as apolipoprotein B (ApoB), lipoprotein (a) [Lp(a)], ...

Scott M. Grundy, MD, PhD. Dr Grundy is director of the Center for Human Nutrition, chairman of the Department of Clinical Nutrition, and professor of internal medicine at the University of Texas ...

This study endeavored to assess the lipid profile and atherogenic lipid indexes in children with transfusion-dependent thalassemia (TDT) and to compare them with matched healthy children. The study ...

The study, say investigators, suggests that reducing LDL cholesterol with lipid-lowering therapies will not be enough to offset the risk associated with atherogenic Lp(a). “You can control LDL ...

The updated 2018 AHA/ACC Multisociety Cholesterol Guideline further refined the secondary prevention category and expanded the scope of primary prevention to include all age groups. This piece offers ...

From the Department of Cardiology and Angiology I, University Heart Center Freiburg, Germany (D.W.) Faculty of Medicine, University of Freiburg, Germany (D.W.) K. Ley has received research funding for ...

L-C has been shown to have benefits for CVD but is also believed to be associated with pro-atherogenic mechanisms. We have previously shown that L-C does not cause plaque progression (no effect) in ...

A major component of the insulin resistance syndrome is dyslipidemia. Alterations in serum lipid levels can be worsened by insulin resistance and represent a leading risk factor for the ...

The Apo A1 to Apo B ratio serves as a valuable marker in assessing cardiovascular risk. A higher ratio indicates a more significant concentration of protective HDL particles relative to atherogenic ...